TOKYO - Japan's Ministry of Health, Labour and Welfare has granted final approval to a group of new products that includes the first regulatory clearances worldwide for two new molecules.
Japan First To Approve Omarigliptin, Lusutrombopag
The latest batch of product approvals in Japan includes the first regulatory clearances worldwide for new molecules from Merck and Shionogi, in a further sign that the country's "drug lag" is a thing of the past.
More from Alimentary/Metabolic
More from Therapy Areas
• By
The company’s FcRn inhibitor nipocalimab was approved by the US FDA for generalized myasthenia gravis (gMG), where it will join a competitive market.
• By
Emma Walmsley tells Scrip that the "biotech market is under a certain degree of pressure," so reasonably priced deals are available.
• By
JAK inhibitor gains ninth indication in US after a strong performance in the first quarter.